Lucid Diagnostics (LUCD) News Today → What’s Really Next for America… (From Porter & Company) (Ad) Free LUCD Stock Alerts $0.95 +0.01 (+1.06%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 4:48 AM | finance.yahoo.comLucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 13 at 8:43 PM | prnewswire.comPAVmed Provides Business Update and First Quarter 2024 Financial ResultsMay 13 at 6:47 PM | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Jasper Therapeutics (JSPR) and Lucid Diagnostics (LUCD)May 13 at 2:34 PM | investorplace.comLUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024May 13 at 9:12 AM | finance.yahoo.comLucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsMay 11 at 5:29 AM | americanbankingnews.comHead to Head Analysis: Shockwave Medical (NASDAQ:SWAV) versus Lucid Diagnostics (NASDAQ:LUCD)May 11 at 1:44 AM | americanbankingnews.comLucid Diagnostics (LUCD) to Release Quarterly Earnings on MondayMay 7, 2024 | prnewswire.comLucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsMay 6, 2024 | marketbeat.comLucid Diagnostics (LUCD) Scheduled to Post Earnings on MondayLucid Diagnostics (NASDAQ:LUCD) will be releasing earnings before the market opens on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=593600)May 2, 2024 | prnewswire.comLucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingApril 29, 2024 | prnewswire.comLucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthApril 26, 2024 | finance.yahoo.comPAVmed Inc. (PAVM)April 21, 2024 | nasdaq.comLucid Diagnostics Inc. Common Stock (LUCD)April 19, 2024 | investorplace.com3 Penny Stocks That Could Make a Big Comeback by the End of Q2April 15, 2024 | markets.businessinsider.comLucid Diagnostics: Strong Buy Rating with Significant Market Potential Despite Near-Term LossesApril 12, 2024 | markets.businessinsider.comBuy Rating Affirmed for Lucid Diagnostics Amidst Strong EsoGuard Testing Growth and Clear Reimbursement PathApril 10, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Lucid Diagnostics (LUCD), Werewolf Therapeutics (HOWL)April 10, 2024 | investing.comLucid Diagnostics holds Buy rating, and stock target on company's performanceMarch 28, 2024 | seekingalpha.comLucid Diagnostics Inc. (LUCD) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | markets.businessinsider.comBuy Rating for Lucid Diagnostics: Solid Test Volumes and Strategic Growth Initiatives Propel Market PositionMarch 28, 2024 | finance.yahoo.comPAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | markets.businessinsider.comBuy Rating Affirmed for Lucid Diagnostics Amid Strong Financials and Strategic Growth InitiativesMarch 27, 2024 | finanznachrichten.dePAVmed Inc.: PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | markets.businessinsider.comBuy Rating Affirmed for Lucid Diagnostics Amidst Growing Test Volume and Strategic Positioning for Medicare ReimbursementMarch 27, 2024 | finance.yahoo.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comQ4 2023 Lucid Diagnostics Inc Earnings CallMarch 25, 2024 | investorplace.comLUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023March 25, 2024 | finance.yahoo.comLucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial ResultsMarch 21, 2024 | markets.businessinsider.comLucid Diagnostics Gets Positive Data From Clinical Validation Study Of EsoGuard Esophageal DNA TestMarch 21, 2024 | prnewswire.comLucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationMarch 20, 2024 | finance.yahoo.comLucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceMarch 11, 2024 | marketbeat.comLucid Diagnostics (LUCD) to Release Earnings on TuesdayLucid Diagnostics (NASDAQ:LUCD) will be releasing earnings on Tuesday, March 12, Yahoo Finance reports.February 21, 2024 | msn.comLucid Diagnostics target oesphageal cancer with early testingFebruary 16, 2024 | prnewswire.comLucid Diagnostics Provides Update Regarding World Trade Center Health ProgramFebruary 16, 2024 | marketbeat.comLucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Up 16.4% in JanuaryLucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 126,600 shares, an increase of 16.4% from the January 15th total of 108,800 shares. Currently, 1.8% of the company's shares are short sold. Based on an average daily volume of 44,700 shares, the short-interest ratio is presently 2.8 days.February 15, 2024 | finance.yahoo.comLucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional TestimonyFebruary 15, 2024 | prnewswire.comLucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional TestimonyFebruary 8, 2024 | finanznachrichten.deLucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and SurvivorsJanuary 30, 2024 | marketbeat.comLucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest UpdateLucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) saw a significant decline in short interest in January. As of January 15th, there was short interest totalling 108,800 shares, a decline of 8.5% from the December 31st total of 118,900 shares. Based on an average daily volume of 40,300 shares, the short-interest ratio is presently 2.7 days. Currently, 1.0% of the shares of the company are short sold.December 30, 2023 | benzinga.comLucid Diagnostics Stock (NASDAQ:LUCD) Dividends: History, Yield and DatesDecember 25, 2023 | finance.yahoo.comThe 3 Most Undervalued Penny Stocks to Buy in DecemberDecember 14, 2023 | za.investing.comNeedham reiterates Buy on Lucid Diagnostics following investor dayDecember 12, 2023 | morningstar.comLucid Diagnostics Inc LUCDDecember 12, 2023 | finance.yahoo.comLucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility StudiesNovember 16, 2023 | finance.yahoo.comLucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | msn.comLucid Diagnostics Non-GAAP EPS of -$0.22 in-line, revenue of $0.8M beats by $0.01MNovember 10, 2023 | benzinga.comEarnings Preview For Lucid DiagnosticsNovember 9, 2023 | msn.comElucid closes $80m Series C for AI cardiovascular risk diagnostic toolNovember 2, 2023 | finance.yahoo.comLucid Diagnostics to Present at Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services ForumNovember 1, 2023 | finance.yahoo.comPAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2023 Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Millionaire Says: “Buy This $11 AI Coin.” (Ad)Right now, you can harness the power of two bull markets... Artificial intelligence...And cryptos. Find out more about this $11 AI Coin right now LUCD Media Mentions By Week LUCD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUCD News Sentiment▼-0.170.57▲Average Medical News Sentiment LUCD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUCD Articles This Week▼101▲LUCD Articles Average Week Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CTSO News AMIX News NSPR News APYX News DRIO News ICCM News XAIR News HSAQ News GBS News PDEX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUCD) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportGuard Against the Coming Financial UpheavalPorter & CompanyDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
